Flexion Therapeutics to Report Third-Quarter 2017 Financial Results on November 6, 2017
October 30 2017 - 4:05PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it
will host a conference call and webcast to provide an update on
business operations and report its third-quarter 2017 financial
results on Monday, November 6, 2017, at 4:30 p.m. ET.
The dial-in number for the conference call is 855-770-0022 for
domestic participants and 908-982-4677 for international
participants, with Conference ID # 7299359. A live webcast of the
conference call can also be accessed through the "Investors" tab on
the Flexion Therapeutics website. A webcast replay will be
available online following the call.
About Flexion Therapeutics Flexion Therapeutics
is a specialty pharmaceutical company focused on the development
and commercialization of novel, local therapies for the treatment
of patients with musculoskeletal conditions, beginning with
osteoarthritis (OA), a type of degenerative arthritis. The
company’s core values are focus, ingenuity, tenacity, transparency
and fun. Flexion was named one of the Boston Business Journal’s
2017 Best Places to Work.
Contact:
Scott YoungSr. Director, Corporate Communications & Investor
RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Sep 2023 to Sep 2024